Ikarian Capital, LLC Astrazeneca PLC Call Options Transaction History

Ikarian Capital, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$66.81 - $80.83 $20.6 Million - $24.9 Million	-308,108 Reduced 99.65%	1,092 $85,000
Q1 2024 May 15, 2024	BUY	$61.03 - $69.57 $18.9 Million - $21.5 Million	309,200 New	309,200 $20.9 Million
Q2 2023 Aug 14, 2023	BUY	$69.91 - $75.81 $17.5 Million - $19 Million	250,000 New	250,000 $17.9 Million
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $5.4 Million - $6.38 Million	-100,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $5.56 Million - $6.08 Million	100,000 New	100,000 $6.01 Million
Q2 2021 Aug 16, 2021	SELL	$48.42 - $60.18 $16.9 Million - $21.1 Million	-350,000 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$48.52 - $58.02 $17 Million - $20.3 Million	350,000 New	350,000 $17.5 Million

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $205B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.